IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RUSSO, DOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.081
EU - Europa 7.647
AS - Asia 3.849
AF - Africa 48
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 26
SA - Sud America 18
Totale 29.698
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.024
UA - Ucraina 2.717
CN - Cina 2.564
DE - Germania 1.080
PL - Polonia 1.006
HK - Hong Kong 898
IT - Italia 851
FI - Finlandia 584
IE - Irlanda 483
GB - Regno Unito 353
SE - Svezia 261
IN - India 161
FR - Francia 156
TR - Turchia 73
SG - Singapore 70
CA - Canada 48
BE - Belgio 46
VN - Vietnam 38
MU - Mauritius 35
RU - Federazione Russa 30
AU - Australia 29
EU - Europa 26
DK - Danimarca 16
NL - Olanda 15
JP - Giappone 10
KR - Corea 9
RO - Romania 9
HU - Ungheria 7
BO - Bolivia 5
BR - Brasile 5
CO - Colombia 5
HR - Croazia 5
IR - Iran 5
AT - Austria 4
EG - Egitto 4
ES - Italia 4
GR - Grecia 4
CH - Svizzera 3
CU - Cuba 3
SA - Arabia Saudita 3
SD - Sudan 3
ZA - Sudafrica 3
BD - Bangladesh 2
ID - Indonesia 2
IQ - Iraq 2
LK - Sri Lanka 2
LV - Lettonia 2
MK - Macedonia 2
MS - Montserrat 2
MX - Messico 2
MY - Malesia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
UG - Uganda 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
HN - Honduras 1
IM - Isola di Man 1
JO - Giordania 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
SI - Slovenia 1
Totale 29.698
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.461
Fairfield 2.430
Jacksonville 1.970
Houston 1.749
Ann Arbor 1.352
Ashburn 1.140
Cambridge 1.084
Warsaw 1.004
Wilmington 966
Princeton 931
Seattle 927
Hong Kong 896
Chandler 798
Nanjing 652
Dublin 479
New York 403
Beijing 307
Helsinki 262
Nanchang 262
Des Moines 210
Brescia 204
San Diego 163
Shenyang 161
Dearborn 148
Changsha 147
Hebei 129
Jinan 121
Milan 113
Shanghai 112
Tianjin 111
Jiaxing 106
Kunming 74
Hangzhou 69
Verona 68
Kocaeli 65
London 57
Ningbo 48
Pune 47
Brussels 46
Lanzhou 40
Zhengzhou 40
Dong Ket 36
San Francisco 35
Norwalk 33
Taizhou 29
Toronto 29
Haikou 27
Orange 26
Guangzhou 22
Grafing 20
Changchun 19
Redwood City 18
Rome 17
Kilburn 16
Hefei 15
Barlassina 12
Boardman 12
Helsingør 12
Taiyuan 12
Chiswick 11
Melbourne 11
Darfo 10
Fuzhou 10
Phoenix 10
Bologna 9
Wandsworth 9
Augusta 8
Brooklyn 8
Canberra 8
Genoa 8
Hounslow 8
Los Angeles 8
North York 8
Turin 8
Bergamo 7
Florence 7
Lappeenranta 7
Prescot 7
Westminster 7
New Bedfont 6
Nürnberg 6
Walnut 6
Budapest 5
Chicago 5
Crema 5
Hanover 5
Leawood 5
Padova 5
Singapore 5
São Paulo 5
Tokyo 5
Battipaglia 4
Breganze 4
Como 4
Falkenstein 4
Naples 4
Osimo 4
Perth 4
Pescara 4
Strasbourg 4
Totale 23.010
Salva come PNG Salva come JPEG
Nome #
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 258
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients 237
BACTERIAL BLOOD STREAM INFECTIONS NEGATIVELY IMPACT ON OUTCOME OF PATIENTS TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION: 6 YEARS SINGLE-CENTRE EXPERIENCE 225
Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation 216
Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain 193
Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia. 192
A standardized flow cytometry network study for the assessment of circulating endothelial cell physiological ranges 188
“Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.” Is dPCR the key? 173
Do chromosomal abnormalities show up during mesenchymal stromal cell expansion? 171
Zebrafish disease models in hematology: Highlights on biological and translational impact 169
Profile of Toll-Like Receptors on Peripheral Blood Cells in Relation to Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation 134
Rational Design and Development of Anisotropic and Mechanically Strong Gelatin-Based Stress Relaxing Hydrogels for Osteogenic/Chondrogenic Differentiation 131
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 131
Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway. 126
Betaherpesvirus Reactivation and Toll-Like Receptor Expression After Allogeneic Stem Cell Transplantation. 125
P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells. 121
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 121
Procoagulant cellular activity and disseminated intravascular coagulation in acute non-lymphoid leukaemia. 120
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 119
Intermittent Imatinib (INTERIM) Treatment of Patients with Ph+ Chronic Myeloid Leukemia in Complete Cytogenetic Response: Cytogenetic and Molecular Data At One Year. 118
EXPRESSION OF TOLL-LIKE RECEPTORS ON PERIPHERAL BLOOD CELLS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: ONGOING RESULTS OF A PROSPECTIVE STUDY. 117
Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target? 116
A specific Toll-like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation 116
TARGETING HRASV12G EXPRESSION TO THE ZEBRAFISH EARLY HEMOGENIC PROGENITORS INDUCES A MYELOPROLIFERATIVE DISORDER BY REPRESSING THE NOTCH PATHWAY. 113
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 112
Fungemia in hematological malignancies: SEIFEM-2015 survey 112
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 112
Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence? 109
Laboratory diagnostics of inherited platelet disorders. 105
Antilymphocyte globulin for prevention of chronic graft-versus-host disease 105
Central nervous system angiitis in Hodgkin's disease. 104
Counting circulating endothelial cells in allo-HSCT: an ad hoc designed polychromatic flowcytometry-based panel versus the CellSearch System 104
Procoagulant cellular activity and disseminated intravascular coagulation in acute non-lymphoid leukaemia 102
Sensitivity of chronic myeloid leukemia hemopoietic progenitors to PTT-119 in combination with human recombinant interferon alpha and gamma 102
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients. 102
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 102
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 101
PARAMETERS OF PROTEIN METABOLISM AND THYROID FUNCTION AS PREDICTORS OF A SCORING SYSTEM FOR ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE 100
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation 100
Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia 100
Sequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantation 99
Peripheral Blood WT1 Expression Predicts Relapse in AML Patients Undergoing Allogeneic Stem Cell Transplantation. 98
Screening of Bcr-Abl transcripts in Philadelphia negative essential thrombocythemia. 97
Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-kit positive acute myeloid leukemia. Results of an italian multicentric phase II study. 97
Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients 97
Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment 97
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 97
Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse 96
Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response. 96
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype. 95
Overexpression of multidrug resistance-associated p170-glycoprotein in acute non-lymphocytic leukemia 95
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 95
Expression of Toll-Like Receptors on Peripheral Blood Cells After Allogeneic Stem Cell Transplantation: Results of a Prospective Study. 95
Long-term follow-up of the Italian trial of interferon- versus conventional chemotherapy in chronic myeloid leukemia 94
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. 94
Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP) 93
Rituximab in a case of cold agglutinin disease 93
Targeting oncogene expression to endothelial cells induces proliferation of the myelo-erythroid lineage by repressing the notch pathway. 93
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: An open-label, multicentre, randomised, phase 3 trial 93
MULTI-GENOTYPING OF MINOR HISTOCOMPATIBILITY ANTIGENS (MHAGS) IN ALLOGENEIC STEM CELL TRANSPLANTATION AND THEIR ROLE IN DETERMINING GRAFT VERSUS HOST DISEASE (GVHD) AND GRAFT VERSUS LEUKEMIA (GVL) EFFECT. 93
A Gene Panel NGS-Based Strategy for Genomic Characterization of Acute Myeloid Leukemias (AMLs) 93
Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing 93
First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response 93
Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF) 93
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia 92
Expression of Toll-like receptors on peripheral blood cells after allogeneic stem cell transplantation: ongoing results of a prospective study. 92
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 92
Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency 92
Quantitative evaluation of BCR-ABL amount of transcript post mobilization with G-CSF of peripheral blood stem cells from chronic myeloid leukemia patients in cytogenetic response. 91
Acute graft-versus-host disease and expression of Toll-like receptors on peripheral blood cells after allogeneic stem cell transplantation 91
Epigenetic regulation of nuclear PI-PLCbeta1 signaling pathway in low-risk MDS patients during azacitidine treatment. 91
Granulocyte-macrophage colony-stimulating factor in acute non-lymphocytic leukemia before and after chemotherapy 90
Treatment of Ph+ chronic myeloid leukemia by gamma interferon 90
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). 90
Index of Bone Marrow Output and Imbalance of B-Lymphocyte Homeostasis before and after Transplantation Correlate Differently with Graft-Versus-Host Disease and Relapse 90
WT1 Monitoring of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia. 90
Monitoring treatment and survival in chronic myeloid leukemia. 89
The role of granulocyte colony-stimulating factor (Filgrastim) in maintaining dose intensity during conventional-dose chemotherapy with ABVD in Hodgkin's disease 89
Changes in Circulating Endothelial Cells Count Could Become a Valuable Tool in the Diagnostic Definition of Acute Graft-Versus-Host Disease. 89
Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease 89
The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era 89
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia – analysis of 848 patients. 88
The expression of the multidrug resistance-associated glycoprotein in B-cell chronic lymphocytic leukaemia 88
Urinary Protein Levels in Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) Predict Severe Disease Related Complications at Myeloma Progression 88
Bortezomib as an Antitumor Agent 87
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases 87
Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients. 87
Laparoscopic splenectomy in the management of hematological diseases 87
Multidrug resistance modulation in vivo: the effect of Cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia 87
SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia. 87
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study. 87
Development of a cell culture model based on biocompatible polymeric scaffolds engineered with human Mesenchymal Stromal Cells (MSCs) for cartilage and bone regenerative therapy 87
Screening for multidrug resistance in leukemia: cell reactivity to MRK-16 correlates with anthracycline retention and sensitivity of leukemic cells. 86
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients. 86
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: A nationwide retrospective survey from Italy 86
Treatment of Chronic Myeloid Leukemia elderly patients in the Tyrosine Kinase Inhibitor era. 86
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib 86
FLAIE (fludarabine, cytarabine, idarubicin and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: a single center experience. 85
Cancer Tissue Procoagulant Mechanisms and the Hypercoagulable State of Patients with Cancer 85
Baseline factors associated with response to ruxolitinib: An independent study on 408 patients with myelofibrosis 85
Totale 10.862
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.114
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.114
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.007 0 0 0 0 0 0 0 0 0 0 497 510
2019/20207.843 1.174 178 218 819 388 932 781 876 576 1.055 235 611
2020/20216.095 85 650 134 845 235 784 272 734 808 700 597 251
2021/20223.507 201 575 65 244 107 230 171 265 196 437 274 742
2022/20232.704 569 96 66 211 213 721 13 229 318 35 105 128
2023/20242.672 162 73 232 167 150 596 159 140 947 41 5 0
Totale 30.692